Aquatic Capital Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229K Sell
13,099
-6,584
-33% -$131K 0.01% 954
2025
Q4
$386K Buy
19,683
+5,250
+36% +$109K 0.01% 812
2025
Q3
$398K Sell
14,433
-10,790
-43% -$332K 0.01% 931
2025
Q2
$770K Buy
25,223
+15,569
+161% +$442K 0.02% 715
2025
Q1
$260K Sell
9,654
-2,211
-19% -$70K 0.01% 893
2024
Q4
$426K Buy
11,865
+8,165
+221% +$305K 0.01% 756
2024
Q3
$140K Buy
3,700
+2,500
+208% +$103K ﹤0.01% 874
2024
Q2
$54.3K Buy
+1,200
New +$55.2K ﹤0.01% 1000
2024
Q1
Sell
-1,000
Closed -$54K 1671
2023
Q4
$54K Sell
1,000
-1,900
-66% -$96.1K ﹤0.01% 1111
2023
Q3
$170K Buy
2,900
+2,700
+1,350% +$169K 0.01% 717
2023
Q2
$13K Sell
200
-2,000
-91% -$127K ﹤0.01% 1178
2023
Q1
$138K Buy
+2,200
New +$131K 0.01% 672
2022
Q1
Sell
-500
Closed -$51K 1558
2021
Q4
$51K Buy
+500
New +$49.9K 0.1% 304

Other funds holding USNA

Aquatic Capital Management's USNA Position: Q1 2026 in Review

Aquatic Capital Management reduced its Usana Health Sciences (USNA) stake by 33% in Q1 2026, selling an estimated $131K and leaving 13,099 shares worth $229K. The position accounts for 0.01% of the portfolio, ranked #954.

Aquatic Capital Management first reported a position in USNA in Q4 2021 and has held it in 13 quarters since. The position peaked at $770K in Q2 2025. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • Aquatic Capital Management held 13,099 shares of Usana Health Sciences worth $229K as of Q1 2026.
  • Aquatic Capital Management sold 6,584 Usana Health Sciences shares in Q1 2026, an estimated $131K.
  • Usana Health Sciences made up 0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #954 holding.
  • Aquatic Capital Management first reported a position in Usana Health Sciences in Q4 2021 and has held it in 13 quarters since.
  • Aquatic Capital Management's Usana Health Sciences position peaked at $770K in Q2 2025.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.